Related Experiment Video

Updated: Sep 13, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K

New insights into the dule roles CDK12 in human cancers: Mechanisms and interventions for cancer therapy

Wei Dai1, Dong Xie2, Hao Huang1

  • 1Jiangxi Province Key Laboratory of Pharmacology of Traditional Chinese Medicine, School of Pharmacy, Gannan Medical University, Ganzhou, Jiangxi, 341000, China.

Journal of Pharmaceutical Analysis
|August 1, 2025
PubMed

Insights

Cyclin-dependent kinase 12 (CDK12) has dual roles in cancer, acting as both an oncogene and tumor suppressor. Understanding its complex functions is crucial for developing targeted cancer therapies and advancing precision oncology.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Cyclin-dependent kinase 12 (CDK12) dysregulation is linked to cancer development and progression.
  • CDK12 alterations can drive tumor initiation, recurrence, and resistance to therapy.
  • CDK12 may also possess context-dependent tumor-suppressive functions.

Purpose of the Study:

  • To provide a comprehensive overview of CDK12 dysregulation and its biological roles in cancer.
  • To systematically summarize the oncogenic and tumor-suppressive functions of CDK12.
  • To discuss CDK12 as a potential therapeutic target in oncology.

Main Methods:

  • Literature review of CDK12's role in cancer.
  • Systematic summary of experimental findings on CDK12 functions.
  • Analysis of clinical implications and future research directions.

Main Results:

  • CDK12 overexpression/activation promotes tumorigenesis and therapeutic resistance.
  • CDK12 can exhibit context-specific tumor-suppressive activities.
  • The dual role necessitates careful consideration for therapeutic targeting.

Conclusions:

  • Elucidating CDK12's dual roles is essential for precision oncology.
  • CDK12 presents a promising, yet complex, therapeutic target.
  • Further research is needed to optimize CDK12-targeted cancer treatment strategies.
Keywords:
CDK12OncogeneTargeted therapyTumor suppressor

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.4K
Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

10.4K

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K